CALCITRIOL-GA calcitriol 0.25 microgram capsule blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

calcitriol, Quantity: 0.25 microgram

Verfügbar ab:

Medis Pharma Pty Ltd

INN (Internationale Bezeichnung):

Calcitriol

Darreichungsform:

Capsule, soft

Zusammensetzung:

Excipient Ingredients: glycerol; sorbitol solution (70 per cent) (non-crystallising); butylated hydroxyanisole; iron oxide yellow; fractionated coconut oil; butylated hydroxytoluene; Gelatin; iron oxide red; purified water

Verabreichungsweg:

Oral

Einheiten im Paket:

100 capsules

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Calcitriol-GA is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of atraumatic fracture. Calcitriol-GA is also indicated for the prevention of corticosteroid-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. Calcitriol-GA is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphataemic rickets.

Produktbesonderheiten:

Visual Identification: Red coloured, oval, soft-gelatin capsules containing a clear, oily liquid.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2014-08-21